High-Sensitivity C-Reactive Protein Modifies P-Wave Terminal Force in Lead V1-Associated Prognosis in Acute Ischemic Stroke or TIA Patients
Open Access
- 3 March 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (5) , 2031
Abstract
Little is known about the role of high-sensitivity C-reactive protein (hsCRP) in the relationship between P-wave terminal force in lead V1 (PTFV1) and stroke prognosis. We aimed to investigate how hsCRP influences the effect of PTFV1 on ischemic stroke recurrence and mortality. In this study, patients enrolled in the Third China National Stroke Registry, which enrolled consecutive patients who had suffered an ischemic stroke or transient ischemic attack in China, were analyzed. After excluding patients with atrial fibrillation, 8271 patients with PTFV1 and hsCRP measurements were included in this analysis. Cox regression analyses were used to assess the association between PTFV1 and stroke prognosis according to different inflammation statuses stratified by an hsCRP level of 3 mg/L. A total of 216 (2.6%) patients died, and 715 (8.6%) patients experienced ischemic stroke recurrence within 1 year. In patients with hsCRP levels ≥ 3 mg/L, elevated PTFV1 was significantly associated with mortality (HR, 1.75; 95% CI, 1.05–2.92; p = 0.03), while in those with hsCRP levels < 3 mg/L, such an association did not exist. In contrast, in patients with hsCRP levels < 3 mg/L and those with hsCRP levels ≥ 3 mg/L, elevated PTFV1 remained significantly associated with ischemic stroke recurrence. The predictive role of PTFV1 towards mortality but not ischemic stroke recurrence differed in terms of hsCRP levels.Keywords
Funding Information
- Capital’s Funds for Health Improvement and Research (2020-1-2041, 2019-I2M-5-029, 81870905, U20A20358)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2020-1-2041, 2019-I2M-5-029, 81870905, U20A20358)
- National Natural Science Foundation of China (2020-1-2041, 2019-I2M-5-029, 81870905, U20A20358)
This publication has 41 references indexed in Scilit:
- Association of atrial fibrillation with mortality and disability after ischemic strokeNeurology, 2013
- Inflammation in Atrial FibrillationJACC, 2012
- Atrial Fibrillation and the Risk of Ischemic StrokeStroke, 2012
- Subclinical Atrial Fibrillation and the Risk of StrokeNew England Journal of Medicine, 2012
- A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in womenEuropean Heart Journal, 2010
- Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for LongevityNutrition Reviews, 2008
- High-Sensitivity C-Reactive Protein and Soluble CD40 Ligand as Indices of Inflammation and Platelet Activation in 880 Patients With Nonvalvular Atrial FibrillationStroke, 2007
- Left atrial function in patients with a high C-reactive protein level and paroxysmal atrial fibrillationActa Cardiologica, 2006
- Is atrial fibrillation an inflammatory disorder?European Heart Journal, 2005
- C-Reactive Protein in Ischemic StrokeStroke, 2001